01 4Natpara
02 2Natpara/Natpar
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2019 Revenue in Millions : 187
2018 Revenue in Millions : 0
Growth (%) : N/A
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2020 Revenue in Millions : 29
2019 Revenue in Millions : 191
Growth (%) : -85
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2021 Revenue in Millions : 41
2020 Revenue in Millions : 28
Growth (%) : 58
Main Therapeutic Indication : Metabolic Diseases
Currency : USD
2022 Revenue in Millions : 11
2021 Revenue in Millions : 41
Growth (%) : -74
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2016 Revenue in Millions : 85
2015 Revenue in Millions : 24
Growth (%) : 254
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2017 Revenue in Millions : 147
2016 Revenue in Millions : 85
Growth (%) : 73
LOOKING FOR A SUPPLIER?
